The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study
Open accessAbstract
IMPORTANCE: The causal direction and magnitude of the association between telomere length and incidence of cancer and non-neoplastic diseases is uncertain owing to the susceptibility of observational studies to confounding and reverse causation. OBJECTIVE: To conduct a Mendelian randomization study, using germline genetic variants as instrumental variables, to appraise the causal relevance of telomere length for risk of cancer and non-neoplastic diseases. DATA SOURCES: Genomewide association studies (GWAS) published up to January 15, 2015. STUDY SELECTION: GWAS of noncommunicable diseases that assayed germline genetic variation and did not select cohort or control participants on the basis of preexisting diseases. Of 163 GWAS of noncommunicable diseases identified, summary data from 103 were available. DATA EXTRACTION AND SYNTHESIS: Summary association statistics for single nucleotide polymorphisms (SNPs) that are strongly associated with telomere length in the general population. MAIN OUTCOMES AND MEASURES: Odds ratios (ORs) and 95% confidence intervals (CIs) for disease per standard deviation (SD) higher telomere length due to germline genetic variation. RESULTS: Summary data were available for 35 cancers and 48 non-neoplastic diseases, corresponding to 420 081 cases (median cases, 2526 per disease) and 1 093 105 controls (median, 6789 per disease). Increased telomere length due to germline genetic variation was generally associated with increased risk for site-specific cancers. The strongest associations (ORs [95% CIs] per 1-SD change in genetically increased telomere length) were observed for glioma, 5.27 (3.15-8.81); serous low-malignant-potential ovarian cancer, 4.35 (2.39-7.94); lung adenocarcinoma, 3.19 (2.40-4.22); neuroblastoma, 2.98 (1.92-4.62); bladder cancer, 2.19 (1.32-3.66); melanoma, 1.87 (1.55-2.26); testicular cancer, 1.76 (1.02-3.04); kidney cancer, 1.55 (1.08-2.23); and endometrial cancer, 1.31 (1.07-1.61). Associations were stronger for rarer cancers and at tissue sites with lower rates of stem cell division. There was generally little evidence of association between genetically increased telomere length and risk of psychiatric, autoimmune, inflammatory, diabetic, and other non-neoplastic diseases, except for coronary heart disease (OR, 0.78 [95% CI, 0.67-0.90]), abdominal aortic aneurysm (OR, 0.63 [95% CI, 0.49-0.81]), celiac disease (OR, 0.42 [95% CI, 0.28-0.61]) and interstitial lung disease (OR, 0.09 [95% CI, 0.05-0.15]). CONCLUSIONS AND RELEVANCE: It is likely that longer telomeres increase risk for several cancers but reduce risk for some non-neoplastic diseases, including cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816 · cited 1×
“178 Sensitivity analyses were based on two approaches: the weighted median(14) and MR-Egger 179 regression.(15) The technical details of these approaches are described below.”
MethodSelf-citationBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922
Self-citationBiological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citation(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010
The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
Welter, D., MacArthur, J., Morales, J., Burdett, T., Hall, P., Junkins, H., Klemm, A., Flicek, P., Manolio, T., Hindorff, L., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1229 · Cited by 2,707
Liu, J. Z., van Sommeren, S., Huang, H., Ng, S. C., Alberts, R., Takahashi, A., Ripke, S., Lee, J. C., Jostins, L., Shah, T., et al. (2015) · Nature Genetics · doi:10.1038/ng.3359 · Cited by 2,603
Self-citationThe new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)
MacArthur, J., Bowler, E., Cerezo, M., Gil, L., Hall, P., Hastings, E., Junkins, H., McMahon, A., Milano, A., Morales, J., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1133 · Cited by 2,161
Cited by
The MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
Self-citationRecent Developments in Mendelian Randomization Studies
Zheng, J., Baird, D., Borges, M.-C., Bowden, J., Hemani, G., Haycock, P., Evans, D. M., & Smith, G. D. (2017) · Current Epidemiology Reports · doi:10.1007/s40471-017-0128-6 · Cited by 1,147
Self-citationZheng, J., Haberland, V., Baird, D., Walker, V., Haycock, P., Hurle, M., Gutteridge, A., Erola, P., Liu, Y., Luo, S., et al. (2019) · doi:10.1101/627398 · Cited by 812
Self-citationGenetic and molecular epidemiology of adult diffuse glioma
Molinaro, A. M., Taylor, J. W., Wiencke, J. K., & Wrensch, M. R. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0220-2 · Cited by 709
Self-citationNon‐small cell lung cancer in China
Chen, P., Liu, Y., Wen, Y., & Zhou, C. (2022) · Cancer Communications · doi:10.1002/cac2.12359 · Cited by 656
Sakalihasan, N., Michel, J.-B., Katsargyris, A., Kuivaniemi, H., Defraigne, J.-O., Nchimi, A., Powell, J. T., Yoshimura, K., & Hultgren, R. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0030-7 · Cited by 641
Self-citationDeterminants of telomere length across human tissues
Demanelis, K., Jasmine, F., Chen, L. S., Chernoff, M., Tong, L., Delgado, D., Zhang, C., Shinkle, J., Sabarinathan, M., Lin, H., et al. (2020) · Science · doi:10.1126/science.aaz6876 · Cited by 515
Self-citationVaiserman, A., & Krasnienkov, D. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.630186 · Cited by 454
Evaluating intrinsic and non-intrinsic cancer risk factors
Wu, S., Zhu, W., Thompson, P., & Hannun, Y. A. (2018) · Nature Communications · doi:10.1038/s41467-018-05467-z · Cited by 437
Self-citationTelomeres and cell senescence—size matters not
Victorelli, S., & Passos, J. F. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.027 · Cited by 413
Telomere Biology and Human Phenotype
Turner, K., Vasu, V., & Griffin, D. (2019) · Cells · doi:10.3390/cells8010073 · Cited by 385
Polygenic basis and biomedical consequences of telomere length variation
Codd, V., Wang, Q., Allara, E., Musicha, C., Kaptoge, S., Stoma, S., Jiang, T., Hamby, S. E., Braund, P. S., Bountziouka, V., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00944-6 · Cited by 379
Self-citationStress and telomere shortening: Insights from cellular mechanisms
Lin, J., & Epel, E. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101507 · Cited by 376
Melzer, D., Pilling, L. C., & Ferrucci, L. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0183-6 · Cited by 363
Telomeres and Telomere Length: A General Overview
Srinivas, N., Rachakonda, S., & Kumar, R. (2020) · Cancers · doi:10.3390/cancers12030558 · Cited by 304
Marnell, C. S., Bick, A., & Natarajan, P. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.07.004 · Cited by 289
Diagnostic utility of telomere length testing in a hospital-based setting
Alder, J. K., Hanumanthu, V. S., Strong, M. A., DeZern, A. E., Stanley, S. E., Takemoto, C. M., Danilova, L., Applegate, C. D., Bolton, S. G., Mohr, D. W., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720427115 · Cited by 268
Targeting telomerase for cancer therapy
Guterres, A. N., & Villanueva, J. (2020) · Oncogene · doi:10.1038/s41388-020-01405-w · Cited by 256
Haycock, P. C., Hemani, G., & Aviv, A. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.2316 · Cited by 209
Self-citationTelomere-mediated lung disease
Alder, J. K., & Armanios, M. (2022) · Physiological Reviews · doi:10.1152/physrev.00046.2021 · Cited by 130
Beginning at the ends: telomeres and human disease
Savage, S. A. (2018) · F1000Research · doi:10.12688/f1000research.14068.1 · Cited by 124
Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells
Nagpal, N., Wang, J., Zeng, J., Lo, E., Moon, D. H., Luk, K., Braun, R. O., Burroughs, L. M., Keel, S. B., Reilly, C., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.03.016 · Cited by 105
Benetos, A., Toupance, S., Gautier, S., Labat, C., Kimura, M., Rossi, P. M., Settembre, N., Hubert, J., Frimat, L., Bertrand, B., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.311751 · Cited by 103
Self-citationMeditation, stress processes, and telomere biology
Conklin, Q. A., Crosswell, A. D., Saron, C. D., & Epel, E. S. (2019) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2018.11.009 · Cited by 69
Shelterin is a dimeric complex with extensive structural heterogeneity
Zinder, J. C., Olinares, P. D. B., Svetlov, V., Bush, M. W., Nudler, E., Chait, B. T., Walz, T., & de Lange, T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2201662119 · Cited by 44
Liu, R., Xiang, M., Pilling, L. C., Melzer, D., Wang, L., Manning, K. J., Steffens, D. C., Bowden, J., Fortinsky, R. H., Kuchel, G. A., et al. (2023) · Aging Cell · doi:10.1111/acel.13808 · Cited by 33
Self-citationChan, K. L., Lo, C. K. M., Chen, X.-Y., Ip, P., Leung, W. C., Shiels, P. G., Pell, J. P., Minnis, H., & Ho, F. K. (2023) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796023000112 · Cited by 3
Metadata
- Authors
- The Telomeres Mendelian Randomization Collaboration, Haycock, P. C., Burgess, S., Nounu, A., Zheng, J., Okoli, G. N., Bowden, J., Wade, K. H., Timpson, N. J., Evans, D. M., Willeit, P., Aviv, A., Gaunt, T. R., Hemani, G., Mangino, M., Ellis, H. P., Kurian, K. M., Pooley, K. A., Eeles, R. A., Lee, J. E., Fang, S., Chen, W. V., Law, M. H., Bowdler, L. M., Iles, M. M., Yang, Q., Worrall, B. B., Markus, H. S., Hung, R. J., Amos, C. I., Spurdle, A. B., Thompson, D. J., O’Mara, T. A., Wolpin, B., Amundadottir, L., Stolzenberg-Solomon, R., Trichopoulou, A., Onland-Moret, N. C., Lund, E., Duell, E. J., Canzian, F., Severi, G., Overvad, K., Gunter, M. J., Tumino, R., Svenson, U., van Rij, A., Baas, A. F., Bown, M. J., Samani, N. J., van t’Hof, F. N. G., Tromp, G., Jones, G. T., Kuivaniemi, H., Elmore, J. R., Johansson, M., Mckay, J., Scelo, G., Carreras-Torres, R., Gaborieau, V., Brennan, P., Bracci, P. M., Neale, R. E., Olson, S. H., Gallinger, S., Li, D., Petersen, G. M., Risch, H. A., Klein, A. P., Han, J., Abnet, C. C., Freedman, N. D., Taylor, P. R., Maris, J. M., Aben, K. K., Kiemeney, L. A., Vermeulen, S. H., Wiencke, J. K., Walsh, K. M., Wrensch, M., Rice, T., Turnbull, C., Litchfield, K., Paternoster, L., Standl, M., Abecasis, G. R., SanGiovanni, J. P., Li, Y., Mijatovic, V., Sapkota, Y., Low, S.-K., Zondervan, K. T., Montgomery, G. W., Nyholt, D. R., van Heel, D. A., Hunt, K., Arking, D. E., Ashar, F. N., Sotoodehnia, N., Woo, D., Rosand, J., Comeau, M. E., Brown, W. M., Silverman, E. K., Hokanson, J. E., Cho, M. H., Hui, J., Ferreira, M. A., Thompson, P. J., Morrison, A. C., Felix, J. F., Smith, N. L., Christiano, A. M., Petukhova, L., Betz, R. C., Fan, X., Zhang, X., Zhu, C., Langefeld, C. D., Thompson, S. D., Wang, F., Lin, X., Schwartz, D. A., Fingerlin, T., Rotter, J. I., Cotch, M. F., Jensen, R. A., Munz, M., Dommisch, H., Schaefer, A. S., Han, F., Ollila, H. M., Hillary, R. P., Albagha, O., Ralston, S. H., Zeng, C., Zheng, W., Shu, X.-O., Reis, A., Uebe, S., Hüffmeier, U., Kawamura, Y., Otowa, T., Sasaki, T., Hibberd, M. L., Davila, S., Xie, G., Siminovitch, K., Bei, J.-X., Zeng, Y.-X., Försti, A., Chen, B., Landi, S., Franke, A., Fischer, A., Ellinghaus, D., Flores, C., Noth, I., Ma, S.-F., Foo, J. N., Liu, J., Kim, J.-W., Cox, D. G., Delattre, O., Mirabeau, O., Skibola, C. F., Tang, C. S., Garcia-Barcelo, M., Chang, K.-P., Su, W.-H., Chang, Y.-S., Martin, N. G., Gordon, S., Wade, T. D., Lee, C., Kubo, M., Cha, P.-C., Nakamura, Y., Levy, D., Kimura, M., Hwang, S.-J., Hunt, S., Spector, T., Soranzo, N., Manichaikul, A. W., Barr, R. G., Kahali, B., Speliotes, E., Yerges-Armstrong, L. M., Cheng, C.-Y., Jonas, J. B., Wong, T. Y., Fogh, I., Lin, K., Powell, J. F., Rice, K., Relton, C. L., Martin, R. M., & Davey Smith, G.
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2017-05-01
- Volume
- 3
- Issue
- 5
- Pages
- 636
- ISSN
- 2374-2437 (ISSN-L)
- OpenAlex
- W2592294322
- Cited by
- 513
- References
- 130
- FWCI
- 35.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.